Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway.

MLA

Zhang, Chao, et al. “Resveratrol Ameliorates Glioblastoma Inflammatory Response by Reducing NLRP3 Inflammasome Activation through Inhibition of the JAK2/STAT3 Pathway.” Journal of Cancer Research & Clinical Oncology, vol. 150, no. 3, Mar. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1007/s00432-024-05625-5.

APA

Zhang, C., Peng, Q., Tang, Y., Wang, C., Wang, S., Yu, D., Hou, S., Wang, Y., Zhang, L., & Lin, N. (2024). Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway. Journal of Cancer Research & Clinical Oncology, 150(3), 1–12. https://doi.org/10.1007/s00432-024-05625-5

Chicago

Zhang, Chao, Qian Peng, Yuhang Tang, Chengcheng Wang, Shuai Wang, Dong Yu, Shiqiang Hou, Yu Wang, Lanlan Zhang, and Ning Lin. 2024. “Resveratrol Ameliorates Glioblastoma Inflammatory Response by Reducing NLRP3 Inflammasome Activation through Inhibition of the JAK2/STAT3 Pathway.” Journal of Cancer Research & Clinical Oncology 150 (3): 1–12. doi:10.1007/s00432-024-05625-5.